U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector transforms.
Source: CNBC
13. February 2025 13:27
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector transforms.
Source: CNBC